Treatment Effectiveness of Venetoclax-Based Therapy After Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: An International Real-World Study

Nilanjan Ghosh; Toby A. Eyre; Jennifer R. Brown; Nicole Lamanna; Beenish S. Manzoor; Catherine C. Coombs; Hande H. Tuncer; Chaitra Ujjani; Lori A. Leslie; Lindsey E. Roeker; Matthew S. Davids; Joanna M. Rhodes; Alan P. Skarbnik; Wendy Sinai; Isabelle Fleury; Brian T. Hill; Nicolas Martinez-Calle; Paul M. Barr; Dureshahwar Jawaid; Nnadozie Emechebe; Laurie Pearson; Frederick Lansigan; Yun Choi; Christopher E. Jensen; Bita Fakhri; Deborah M. Stephens; Steven E. Marx; Stephen J. Schuster; Michael Coyle; Irina Pivneva; Talissa Watson; Annie Guerin; Mazyar Shadman

doi:10.1002/ajh.27563

Treatment Effectiveness of Venetoclax-Based Therapy After Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: An International Real-World Study

Nilanjan Ghosh
, Toby A. Eyre
, Jennifer R. Brown
, Nicole Lamanna
, Beenish S. Manzoor
, Catherine C. Coombs
, Hande H. Tuncer
, Chaitra Ujjani
, Lori A. Leslie
, Lindsey E. Roeker
, Matthew S. Davids
, Joanna M. Rhodes
, Alan P. Skarbnik
, Wendy Sinai
, Isabelle Fleury
, Brian T. Hill
, Nicolas Martinez-Calle
, Paul M. Barr
, Dureshahwar Jawaid
, Nnadozie Emechebe

Laurie Pearson, Frederick Lansigan, Yun Choi, Christopher E. Jensen, Bita Fakhri, Deborah M. Stephens, Steven E. Marx, Stephen J. Schuster, Michael Coyle, Irina Pivneva, Talissa Watson, Annie Guerin, Mazyar Shadman

School of Medicine

Wake Forest University
University of Oxford
Dana-Farber Cancer Institute
Columbia University
AbbVie
University of California at Irvine
Fred Hutchinson Cancer Research Center
Memorial Sloan-Kettering Cancer Center
Rutgers - The State University of New Jersey, New Brunswick
Novant Health Cancer Institute
University of Montreal
Cleveland Clinic Foundation
Nottingham University Hospitals NHS Trust
University of Rochester
University of Massachusetts Boston
Dartmouth–Hitchcock Medical Center
Tufts Medical Center
The University of North Carolina at Chapel Hill
Stanford University
University of Pennsylvania
Lowell General Hospital

Research output: Contribution to journal › Letter › peer-review

10 Scopus citations

Original language	English
Pages (from-to)	511-515
Number of pages	5
Journal	American Journal of Hematology
Volume	100
Issue number	3
DOIs	https://doi.org/10.1002/ajh.27563
State	Published - Mar 2025

Keywords

Bruton tyrosine kinase inhibitor
chronic lymphocytic leukemia
real-world outcomes
venetoclax

Access to Document

10.1002/ajh.27563

Cite this

Ghosh, N., Eyre, T. A., Brown, J. R., Lamanna, N., Manzoor, B. S., Coombs, C. C., Tuncer, H. H., Ujjani, C., Leslie, L. A., Roeker, L. E., Davids, M. S., Rhodes, J. M., Skarbnik, A. P., Sinai, W., Fleury, I., Hill, B. T., Martinez-Calle, N., Barr, P. M., Jawaid, D., ... Shadman, M. (2025). Treatment Effectiveness of Venetoclax-Based Therapy After Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: An International Real-World Study. American Journal of Hematology, 100(3), 511-515. https://doi.org/10.1002/ajh.27563

@article{0923d53845b3447181b35f836669085f,

title = "Treatment Effectiveness of Venetoclax-Based Therapy After Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: An International Real-World Study",

keywords = "Bruton tyrosine kinase inhibitor, chronic lymphocytic leukemia, real-world outcomes, venetoclax",

author = "Nilanjan Ghosh and Eyre, \{Toby A.\} and Brown, \{Jennifer R.\} and Nicole Lamanna and Manzoor, \{Beenish S.\} and Coombs, \{Catherine C.\} and Tuncer, \{Hande H.\} and Chaitra Ujjani and Leslie, \{Lori A.\} and Roeker, \{Lindsey E.\} and Davids, \{Matthew S.\} and Rhodes, \{Joanna M.\} and Skarbnik, \{Alan P.\} and Wendy Sinai and Isabelle Fleury and Hill, \{Brian T.\} and Nicolas Martinez-Calle and Barr, \{Paul M.\} and Dureshahwar Jawaid and Nnadozie Emechebe and Laurie Pearson and Frederick Lansigan and Yun Choi and Jensen, \{Christopher E.\} and Bita Fakhri and Stephens, \{Deborah M.\} and Marx, \{Steven E.\} and Schuster, \{Stephen J.\} and Michael Coyle and Irina Pivneva and Talissa Watson and Annie Guerin and Mazyar Shadman",

year = "2025",

month = mar,

doi = "10.1002/ajh.27563",

language = "English",

volume = "100",

pages = "511--515",

journal = "American Journal of Hematology",

issn = "0361-8609",

publisher = "John Wiley and Sons Inc",

number = "3",

}

Ghosh, N, Eyre, TA, Brown, JR, Lamanna, N, Manzoor, BS, Coombs, CC, Tuncer, HH, Ujjani, C, Leslie, LA, Roeker, LE, Davids, MS, Rhodes, JM, Skarbnik, AP, Sinai, W, Fleury, I, Hill, BT, Martinez-Calle, N, Barr, PM, Jawaid, D, Emechebe, N, Pearson, L, Lansigan, F, Choi, Y, Jensen, CE, Fakhri, B, Stephens, DM, Marx, SE, Schuster, SJ, Coyle, M, Pivneva, I, Watson, T, Guerin, A & Shadman, M 2025, 'Treatment Effectiveness of Venetoclax-Based Therapy After Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: An International Real-World Study', American Journal of Hematology, vol. 100, no. 3, pp. 511-515. https://doi.org/10.1002/ajh.27563

TY - JOUR

T1 - Treatment Effectiveness of Venetoclax-Based Therapy After Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia

T2 - An International Real-World Study

AU - Ghosh, Nilanjan

AU - Eyre, Toby A.

AU - Brown, Jennifer R.

AU - Lamanna, Nicole

AU - Manzoor, Beenish S.

AU - Coombs, Catherine C.

AU - Tuncer, Hande H.

AU - Ujjani, Chaitra

AU - Leslie, Lori A.

AU - Roeker, Lindsey E.

AU - Davids, Matthew S.

AU - Rhodes, Joanna M.

AU - Skarbnik, Alan P.

AU - Sinai, Wendy

AU - Fleury, Isabelle

AU - Hill, Brian T.

AU - Martinez-Calle, Nicolas

AU - Barr, Paul M.

AU - Jawaid, Dureshahwar

AU - Emechebe, Nnadozie

AU - Pearson, Laurie

AU - Lansigan, Frederick

AU - Choi, Yun

AU - Jensen, Christopher E.

AU - Fakhri, Bita

AU - Stephens, Deborah M.

AU - Marx, Steven E.

AU - Schuster, Stephen J.

AU - Coyle, Michael

AU - Pivneva, Irina

AU - Watson, Talissa

AU - Guerin, Annie

AU - Shadman, Mazyar

PY - 2025/3

Y1 - 2025/3

KW - Bruton tyrosine kinase inhibitor

KW - chronic lymphocytic leukemia

KW - real-world outcomes

KW - venetoclax

UR - https://www.scopus.com/pages/publications/85212484603

U2 - 10.1002/ajh.27563

DO - 10.1002/ajh.27563

M3 - Letter

C2 - 39698781

AN - SCOPUS:85212484603

SN - 0361-8609

VL - 100

SP - 511

EP - 515

JO - American Journal of Hematology

JF - American Journal of Hematology

IS - 3

ER -

Treatment Effectiveness of Venetoclax-Based Therapy After Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: An International Real-World Study

Keywords

Access to Document

Other files and links

Cite this